AVBP
ArriVent BioPharma, Inc.
30.30$
-0.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | +536.0% | +111.1% | +258.4% | +290.3% | |
| – | – | – | -43.9% | -153.4% | |
| – | – | – | – | – | |
| – | – | – | – | -63.0% | |
| – | – | – | – | – | |
| – | +88.9% | -74.7% | +335.3% | +8.8% | |
| – | +238.2% | -110.3% | – | – | |
| – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.